Clinical Trial Update: A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the safety and effectiveness of Prevenar in pneumococcal vaccine-naive Chinese children; results have been posted after completion in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Prevenar (pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Infections | Phase 4 | Status: COMPLETED | Results posted: 2013-11-20